CYP2A6 and hepatocellular carcinoma: KM survival curves showed that HCC patients with higher CYP2A6, CYP2C9, FMO3, and SEC14L2 protein expressions had longer OS and those of higher G6PD had shorter OS in the CPTAC cohort (Figures 6C–G).